Artificial Intelligence (ai) In Drug Discovery Market

Artificial Intelligence (ai) In Drug Discovery Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

149

Base Year:

2022

Jul - 2023

Format:

Report Code:

VMR-2220

Segments Covered

By Application Drug Optimization & Repurposing, Preclinical Testing, Other Applications
By Therapeutic Area Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Other Areas
By Component Software, Hardware, Services
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 1.3 Billion
Revenue 2030:	USD 7.1 Billion
Revenue CAGR (2023 - 2030):	23.72%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Artificial Intelligence (ai) In Drug Discovery Market - Segment Analysis
1. Overview
2. Global Artificial Intelligence (ai) In Drug Discovery Market, 2016 - 2028 (USD Million)
3. Global Artificial Intelligence (ai) In Drug Discovery Market - by Application
  1. By Drug Optimization & Repurposing
  2. By Preclinical Testing
  3. By Other Applications
4. Global Artificial Intelligence (ai) In Drug Discovery Market - by Therapeutic Area
  1. By Oncology
  2. By Neurodegenerative Diseases
  3. By Cardiovascular Diseases
  4. By Metabolic Diseases
  5. By Infectious Diseases
  6. By Other Areas
5. Global Artificial Intelligence (ai) In Drug Discovery Market - by Component
  1. By Software
  2. By Hardware
  3. By Services
6. Global Artificial Intelligence (ai) In Drug Discovery Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Artificial Intelligence (ai) In Drug Discovery Market - Segment Analysis
1. Overview
2. North America Artificial Intelligence (ai) In Drug Discovery Market, 2016 - 2028 (USD Million)
3. North America Artificial Intelligence (ai) In Drug Discovery Market, by Application
  1. By Drug Optimization & Repurposing
  2. By Preclinical Testing
  3. By Other Applications
4. North America Artificial Intelligence (ai) In Drug Discovery Market, by Therapeutic Area
  1. By Oncology
  2. By Neurodegenerative Diseases
  3. By Cardiovascular Diseases
  4. By Metabolic Diseases
  5. By Infectious Diseases
  6. By Other Areas
5. North America Artificial Intelligence (ai) In Drug Discovery Market, by Component
  1. By Software
  2. By Hardware
  3. By Services
6. North America Artificial Intelligence (ai) In Drug Discovery Market, by Country
  1. U.S.
    1. U.S. Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. U.S. Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. U.S. Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  2. Canada
    1. Canada Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. Canada Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. Canada Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  3. Mexico
    1. Mexico Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. Mexico Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. Mexico Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
Europe Artificial Intelligence (ai) In Drug Discovery Market - Segment Analysis
1. Overview
2. Europe Artificial Intelligence (ai) In Drug Discovery Market, 2016 - 2028 (USD Million)
3. Europe Artificial Intelligence (ai) In Drug Discovery Market, by Application
  1. By Drug Optimization & Repurposing
  2. By Preclinical Testing
  3. By Other Applications
4. Europe Artificial Intelligence (ai) In Drug Discovery Market, by Therapeutic Area
  1. By Oncology
  2. By Neurodegenerative Diseases
  3. By Cardiovascular Diseases
  4. By Metabolic Diseases
  5. By Infectious Diseases
  6. By Other Areas
5. Europe Artificial Intelligence (ai) In Drug Discovery Market, by Component
  1. By Software
  2. By Hardware
  3. By Services
6. Europe Artificial Intelligence (ai) In Drug Discovery Market, by Country
  1. Germany
    1. Germany Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. Germany Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. Germany Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  2. UK
    1. UK Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. UK Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. UK Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  3. France
    1. France Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. France Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. France Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  4. Spain
    1. Spain Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. Spain Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. Spain Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  5. Italy
    1. Italy Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. Italy Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. Italy Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  6. BENELUX
    1. BENELUX Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. BENELUX Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. BENELUX Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  7. Rest of Europe
    1. Rest Of Europe Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. Rest Of Europe Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. Rest Of Europe Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market - Segment Analysis
1. Overview
2. Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market, 2016 - 2028 (USD Million)
3. Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market, by Application
  1. By Drug Optimization & Repurposing
  2. By Preclinical Testing
  3. By Other Applications
4. Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market, by Therapeutic Area
  1. By Oncology
  2. By Neurodegenerative Diseases
  3. By Cardiovascular Diseases
  4. By Metabolic Diseases
  5. By Infectious Diseases
  6. By Other Areas
5. Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market, by Component
  1. By Software
  2. By Hardware
  3. By Services
6. Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market, by Country
  1. China
    1. China Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. China Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. China Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  2. Japan
    1. Japan Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. Japan Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. Japan Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  3. India
    1. India Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. India Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. India Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  4. South Korea
    1. South Korea Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. South Korea Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. South Korea Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  5. South East Asia
    1. South East Asia Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. South East Asia Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. South East Asia Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. Rest of Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. Rest of Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
Latin America Artificial Intelligence (ai) In Drug Discovery Market - Segment Analysis
1. Overview
2. Latin America Artificial Intelligence (ai) In Drug Discovery Market, 2016 - 2028 (USD Million)
3. Latin America Artificial Intelligence (ai) In Drug Discovery Market, by Application
  1. By Drug Optimization & Repurposing
  2. By Preclinical Testing
  3. By Other Applications
4. Latin America Artificial Intelligence (ai) In Drug Discovery Market, by Therapeutic Area
  1. By Oncology
  2. By Neurodegenerative Diseases
  3. By Cardiovascular Diseases
  4. By Metabolic Diseases
  5. By Infectious Diseases
  6. By Other Areas
5. Latin America Artificial Intelligence (ai) In Drug Discovery Market, by Component
  1. By Software
  2. By Hardware
  3. By Services
6. Latin America Artificial Intelligence (ai) In Drug Discovery Market, by Country
  1. Brazil
    1. Brazil Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. Brazil Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. Brazil Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  2. Argentina
    1. Argentina Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. Argentina Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. Argentina Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  3. Rest of Latin America
    1. Rest of Latin America Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. Rest of Latin America Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. Rest of Latin America Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market - Segment Analysis
1. Overview
2. Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market, by Application
  1. By Drug Optimization & Repurposing
  2. By Preclinical Testing
  3. By Other Applications
4. Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market, by Therapeutic Area
  1. By Oncology
  2. By Neurodegenerative Diseases
  3. By Cardiovascular Diseases
  4. By Metabolic Diseases
  5. By Infectious Diseases
  6. By Other Areas
5. Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market, by Component
  1. By Software
  2. By Hardware
  3. By Services
6. Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market, by Country
  1. GCC Countries
    1. GCC Countries Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. GCC Countries Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. GCC Countries Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  2. South Africa
    1. South Africa Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. South Africa Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. South Africa Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market, By Application
      1. By Drug Optimization & Repurposing
      2. By Preclinical Testing
      3. By Other Applications
    2. Rest of Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market, By Therapeutic Area
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Diseases
      4. By Metabolic Diseases
      5. By Infectious Diseases
      6. By Other Areas
    3. Rest of Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market, By Component
      1. By Software
      2. By Hardware
      3. By Services
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. IBM Watson (U.S.)
2. Exscientia (UK)
3. GNS Healthcare (U.S.)
4. Alphabet (U.S.)
5. Benevolent AI (UK)
6. BioSymetrics Inc. (Canada)
7. Euretos (Netherlands)
8. Berg Health (U.S.)
9. Atomwise (U.S.)
10. Insitro (U.S.)
11. Cyclica Inc. (Canada)
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Artificial Intelligence (ai) In Drug Discovery in terms of revenue?

The global Artificial Intelligence (ai) In Drug Discovery valued at USD 1.3 Billion in 2022 and is expected to reach USD 7.1 Billion in 2030 growing at a CAGR of 23.72%.

Which are the prominent players in the market?

The prominent players in the market are IBM Watson (U.S.), Exscientia (UK), GNS Healthcare (U.S.), Alphabet (U.S.), Benevolent AI (UK), BioSymetrics Inc. (Canada), Euretos (Netherlands), Berg Health (U.S.), Atomwise (U.S.), Insitro (U.S.), Cyclica Inc. (Canada).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 23.72% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Artificial Intelligence (ai) In Drug Discovery include
- Growing number of cross industry collaboration and partnerships

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Artificial Intelligence (ai) In Drug Discovery in 2022.

Artificial Intelligence (ai) In Drug Discovery Market

Artificial Intelligence (ai) In Drug Discovery Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Artificial Intelligence (ai) In Drug Discovery in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Artificial Intelligence (ai) In Drug Discovery Market

Artificial Intelligence (ai) In Drug Discovery Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Artificial Intelligence (ai) In Drug Discovery in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Artificial Intelligence (ai) In Drug Discovery Market

Vantage Point Interactive Dashboard